Chemoinformaics analysis of 7-Formylcyclopenta[c]pyran-4-carboxylic acid
| Molecular Weight | 474.33 | nRot | 6 |
| Heavy Atom Molecular Weight | 460.218 | nRig | 26 |
| Exact Molecular Weight | 474.043 | nRing | 3 |
| Solubility: LogS | -6.284 | nHRing | 0 |
| Solubility: LogP | 5.624 | No. of Aliphatic Rings | 0 |
| Acid Count | 3 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 48 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 3 |
| nHetero | 13 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 18 |
| No. of Oxygen atom | 13 | No. of Arom Bond | 18 |
| nHA | 10 | APOL | 54.8311 |
| nHD | 9 | BPOL | 18.3849 |
| QED | 0.663 |
| Synth | 5.632 |
| Natural Product Likeliness | 1.612 |
| NR-PPAR-gamma | 0.969 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.999 |
| Pgp-sub | 0.004 |
| HIA | 0.004 |
| CACO-2 | -4.993 |
| MDCK | 0.0000225 |
| BBB | 0.03 |
| PPB | 1.00194 |
| VDSS | 2.499 |
| FU | 0.0240829 |
| CYP1A2-inh | 0.492 |
| CYP1A2-sub | 0.596 |
| CYP2c19-inh | 0.853 |
| CYP2c19-sub | 0.854 |
| CYP2c9-inh | 0.921 |
| CYP2c9-sub | 0.106 |
| CYP2d6-inh | 0.771 |
| CYP2d6-sub | 0.182 |
| CYP3a4-inh | 0.955 |
| CYP3a4-sub | 0.375 |
| CL | 9.335 |
| T12 | 0.021 |
| hERG | 0.365 |
| Ames | 0.017 |
| ROA | 0.878 |
| SkinSen | 0.96 |
| Carcinogencity | 0.856 |
| EI | 0.021 |
| Respiratory | 0.804 |
| NR-Aromatase | 0.901 |
| Antiviral | Yes |
| Prediction | 0.802929 |